Sucee

Sucee Warnings

cyproterone + ethinylestradiol

Manufacturer:

Biolab

Distributor:

Biopharm
Full Prescribing Info
Warnings
Smoking: Cigarette smoking increases the risk of serious cardiovascular side effect from SUCEE. This risk increases with age and with heavy smoking (≥ 15 cigarettes per day) and is quite marked in women > 35 years of age. Women who use SUCEE should not smoke.
Thromboembolism: Be alert to the earliest symptoms of thromboembolic and thrombotic disorders. Should any of these occur or be suspected, discontinue the drug immediately.
MI: MI risk associated with SUCEE use is increased. The risk is primarily in smokers or women with other underlying risk factors for coronary artery disease such as hypertension, hypercholesterolemia, morbid obesity and diabetes. The risk is very low in women < 30 years of age.
Cerebrovascular diseases: SUCEE increase the risk of cerebrovascular event (thrombotic and hemorrhagic strokes), although, in general, the risk is greatest in hypertensive women > 35 years of age who also smoke.
Age: The risk of cerebrovascular and circulatory disease in SUCEE users is substantially increased in women ≥ 35 years of age with other risk factor (e.g. smoking, uncontrolled hypertension, hypercholesterolemia [LDL 190], obesity, diabetes).
Carcinoma: Numerous epidemiological studies have been performed on the incidence of breast, endometrial, ovarian, and cervical cancer in using combined oral contraceptives.
Some studies suggest that oral contraceptive use has been associated with an increase in the risk of cervical intraepithelial neoplasia in some women. There continues to be controversy about the extent to which such findings may be because of differences in sexual behavior and other factors.
Close clinical surveillance of all women taking oral contraceptives is essential; they should be reexamined at least once a year. Monitor women with a strong family history of breast cancer or who have breast nodules, fibrocystic disease of the breast, cervical dysplasia or abnormal mammograms.
Benign and malignant hepatic adenomas have been associated with the use of oral contraceptives, but this is a relatively rare disease.
Elevated blood pressure: Elevated blood pressure and hypertension may occur within a few months of beginning use. High blood pressure returns to normal in most women after oral contraceptives discontinuation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in